DexCom’s stock is headed for its worst selloff ever. Not everyone thinks it’s justified.
Shares of DexCom Inc. tumbled more than 40% on Friday and were headed for their worst percentage drop on record, a day after the maker of diabetes-management equipment shocked investors with a cut to its sales forecast that heightened concerns about growing global competition and the company’s prospects overall.
